{"id":12144,"date":"2023-02-03T04:13:22","date_gmt":"2023-02-02T20:13:22","guid":{"rendered":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144"},"modified":"2023-02-03T04:13:22","modified_gmt":"2023-02-02T20:13:22","slug":"yu-wensheng-et-al-published-their-research-in-bioorganic-medicinal-chemistry-letters-in-2010-cas-73387-46-9-2","status":"publish","type":"post","link":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144","title":{"rendered":"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9"},"content":{"rendered":"<p>Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.<a href=\"https:\/\/www.ambeed.com\/products\/73387-46-9.html\">Related Products of 73387-46-9<\/a> This article mentions the following:<\/p>\n<p>We disclose further optimization of hydantoin TNF-\u03b1 convertase enzyme (TACE) inhibitors. SAR with respect to the non-prime region of TACE active site was explored. A series of biaryl substituted hydantoin compounds was shown to have sub-nanomolar K <sub>i<\/sub>, good rat PK, and good selectivity vs. MMP-1, -2, -3, -7, -9, and -13. In the experiment, the researchers used many compounds, for example, 3-(4-Bromophenyl)-1H-pyrazole (cas: 73387-46-9<a href=\"https:\/\/www.ambeed.com\/products\/73387-46-9.html\">Related Products of 73387-46-9<\/a>).<\/p>\n<p>3-(4-Bromophenyl)-1H-pyrazole (cas: 73387-46-9) belongs to pyrazole derivatives. As is the case with imidazoles, the pyrazole ring offers many opportunities to create new multiring systems that incorporate this heterocycle. Pyrazoles and pyrimidines have diverse biological and pharmacological activities. There are a number of antimicrobial compounds containing pyrazole moiety as the core unit. Pyrazofurin is important antimicrobial drug and 2-methylpyrimidine-4-ylamine derivatives I and II were found to be effective inhibitors of Escherichia coli PDHc-E1 with antibacterial and antifungal activity.<a href=\"https:\/\/www.ambeed.com\/products\/73387-46-9.html\">Related Products of 73387-46-9<\/a><\/p>\n<p>Referemce:<br \/><a href=\"https:\/\/en.wikipedia.org\/wiki\/Pyrazole\">Pyrazole &#8211; Wikipedia<\/a>,<br \/><a href=\"https:\/\/www.sciencedirect.com\/topics\/chemistry\/pyrazoles\">Pyrazoles &#8211; an overview | ScienceDirect Topics<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>3-(4-Bromophenyl)-1H-pyrazole (cas: 73387-46-9) belongs to pyrazole derivatives. As is the case with imidazoles, the pyrazole ring offers many opportunities to create new multiring systems that incorporate this heterocycle. Pyrazoles and pyrimidines have diverse biological and pharmacological activities. There are a number of antimicrobial compounds containing pyrazole moiety as the core unit. Pyrazofurin is important antimicrobial drug and 2-methylpyrimidine-4-ylamine derivatives I and II were found to be effective inhibitors of Escherichia coli PDHc-E1 with antibacterial and antifungal activity.<a href=\"https:\/\/www.ambeed.com\/products\/73387-46-9.html\">Related Products of 73387-46-9<\/a><\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[131],"tags":[129],"class_list":["post-12144","post","type-post","status-publish","format-standard","hentry","category-pyrazoles-derivatives","tag-200-300"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives<\/title>\n<meta name=\"description\" content=\"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives\" \/>\n<meta property=\"og:description\" content=\"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144\" \/>\n<meta property=\"og:site_name\" content=\"pyrazoles-derivatives\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T20:13:22+00:00\" \/>\n<meta name=\"author\" content=\"Jessica.F\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica.F\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144\",\"url\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144\",\"name\":\"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives\",\"isPartOf\":{\"@id\":\"http:\/\/www.pyrazoles-derivatives.com\/#website\"},\"datePublished\":\"2023-02-02T20:13:22+00:00\",\"author\":{\"@id\":\"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\"},\"description\":\"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12144#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"http:\/\/www.pyrazoles-derivatives.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/www.pyrazoles-derivatives.com\/#website\",\"url\":\"http:\/\/www.pyrazoles-derivatives.com\/\",\"name\":\"pyrazoles-derivatives\",\"description\":\"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\",\"name\":\"Jessica.F\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/weavatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/weavatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"caption\":\"Jessica.F\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives","description":"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144","og_locale":"en_US","og_type":"article","og_title":"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives","og_description":"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:","og_url":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144","og_site_name":"pyrazoles-derivatives","article_published_time":"2023-02-02T20:13:22+00:00","author":"Jessica.F","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jessica.F","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144","url":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144","name":"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9 | pyrazoles-derivatives","isPartOf":{"@id":"http:\/\/www.pyrazoles-derivatives.com\/#website"},"datePublished":"2023-02-02T20:13:22+00:00","author":{"@id":"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1"},"description":"Biaryl substituted hydantoin compounds as TACE inhibitors was written by Yu, Wensheng;Tong, Ling;Kim, Seong Heon;Wong, Michael K. C.;Chen, Lei;Yang, De-Yi;Shankar, Bandarpalle B.;Lavey, Brian J.;Zhou, Guowei;Kosinski, Aneta;Rizvi, Razia;Li, Dansu;Feltz, Robert J.;Piwinski, John J.;Rosner, Kristin E.;Shih, Neng-Yang;Siddiqui, M. Arshad;Guo, Zhuyan;Orth, Peter;Shah, Himanshu;Sun, Jing;Umland, Shelby;Lundell, Daniel J.;Niu, Xiaoda;Kozlowski, Joseph A.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2010.Related Products of 73387-46-9 This article mentions the following:","breadcrumb":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pyrazoles-derivatives.com\/?p=12144"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12144#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"http:\/\/www.pyrazoles-derivatives.com\/"},{"@type":"ListItem","position":2,"name":"Yu, Wensheng et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2010 | CAS: 73387-46-9"}]},{"@type":"WebSite","@id":"http:\/\/www.pyrazoles-derivatives.com\/#website","url":"http:\/\/www.pyrazoles-derivatives.com\/","name":"pyrazoles-derivatives","description":"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1","name":"Jessica.F","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/","url":"https:\/\/weavatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","contentUrl":"https:\/\/weavatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","caption":"Jessica.F"}}]}},"_links":{"self":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/12144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12144"}],"version-history":[{"count":0,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/12144\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}